openPR Logo
Press release

Contraceptives Market to Incur Rapid Extension During 2025

10-04-2017 12:10 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Contraceptives Market to Incur Rapid Extension During 2025

As per estimates by Transparency Market Research, the global contraceptives market will reach a valuation of US$37,242.7 mn by the end of 2025 from a valuation of US$22,050.0 mn in 2016 at a CAGR of 6.1% between 2017 and 2025.

Amongst the key product types, contraceptive devices holds dominance with the segment holding 53.2% market share in 2016. Hospital pharmacy leads among the key distribution channels on account of a number of favorable factors. Geography-wise, North America holds lucrative growth prospects among other key markets for contraceptives. However, Asia Pacific is poised to display the leading growth rate over the forecast period.

View and Download TOC of Contraceptives Market Research Report@ https://www.transparencymarketresearch.com/report-toc/344

Celebrity Endorsement of Awareness Campaigns Uptakes Adoption among Young Adults

Among the key factors driving the global contraceptives market is the increasing number of awareness campaigns that propagate contraceptives to be the effective method to prevent unintended pregnancies, which is leading to their increased adoption among young and adolescent population in both developed and developing countries. The campaigns that are generally undertaken by government agencies and NGOs are endorsed by celebrities, which is favoring the use of contraceptives among young adults who have the mindset to imitate famous people.

Further, the awareness campaigns also offer expert guidance about adoption of most effective method of contraception depending on individual need. Woman’s overall health, age, frequency of sexual activity, desire to have children in future, and family history are some of the factors that gynecologists look into before advising the method of contraception.

In developing regions, especially among the urban population, modern education and career aspirations have been crucial factors for the increasing adoption of contraceptives. Increasing number of women in the workforce and nuclear family setups are leading to increasing use of contraceptives for delayed pregnancies. Couples are increasingly seeking expert help for advice regarding the method of contraception to be adopted and guidance regarding family planning that suit their need.

Apart from this, the rising prevalence of sexually transmitted diseases is also leading to the uptake of contraceptives. This is because contraceptives such as condoms and topical contraceptive patch are effective to prevent sexually transmitted diseases such as AIDS in the event of sexual activity with multiple partners.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344

Lastly, development of novel contraceptive products by leading key players is also acting in favor of the global contraceptives market.

Chances of Side Effects Challenge Growth

On the downside, side effects associated with hormonal contraception is slowing the adoption of these products among wary consumers. Rising infertility is also proving to be a major restraint on the growth of contraceptives market.

The global contraceptives market displays intense competition with the presence of a multitude of key players that operate globally, says Transparency Market Research (TMR) in a new study. Despite this, Bayer AG stood as the clear leader in 2016 attributed to its diverse product portfolio and strong global presence. This has led other key players to develop novel contraception products for competitive gains.

Some other prominent participants in the global contraceptives market are Cipla Inc., Merck Co. Inc., Mankind Pharma, Teva Pharmaceutical Industries Ltd., Janssen Pharmaceutical Company, Allergan plc, HLL Lifecare Limited, Pfizer Inc., Mithra Pharmaceuticals, and Reckitt Benckiser plc among others.

Buy Full Contraceptives Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=344<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contraceptives Market to Incur Rapid Extension During 2025 here

News-ID: 754781 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Contraceptives

Hormonal Contraceptives Market Size, Share | Hormonal Contraceptives Industry Fu …
Global Hormonal Contraceptives Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hormonal Contraceptives Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Potential Opportunities of Contraceptives Market
The global contraceptives market, valued at US$ 20,111.6 Mn in 2017, is set to jump to US$ 31,666.9 mn by 2025, according to a report published by Fortune Business Insights, titled "Contraceptives Market Size, Share and Global Trend By Product Type (Contraceptive Drugs & Contraceptive Devices), By Gender (Male & Female), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO & Others), and Geography Forecast
Contraceptives Market Trends And Forecast 2015 - 2025
Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which not only inhibit pregnancy but also sexually transmitted diseases (STDs). The contraceptive devices are available in various forms such as coil, loop, triangle, and T-shaped, and are made of plastic or metal. Currently the trend witnessed
Contraceptives Market to Develop Rapidly by 2025
The worldwide Contraceptives Market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years. Some other major firms in the contraceptives market are Cipla Inc., Mankind
Global Contraceptives Market: Market Segmentation
The worldwide contraceptives market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years. Some other major firms in the contraceptives market are Cipla Inc., Mankind
Contraceptives Market Size - Industry Share Report 2021
The Global Contraceptives Market was worth $ 21.5 billion in 2016 and estimated to reach $ 29.60 billion by the end of 2021 with a growing potential of 6.6 %. Contraceptives market is predicted to grow rapidly due to increasing awareness in making right decisions about their sexual and reproductive health. Full report at: http://www.marketdataforecast.com/market-reports/global-contraceptives-market-1228/ Contraception is a prevention of pregnancy by interfering with normal process of fertilization, ovulation and implantation through the